REQUEST A DEMO
Total
USD $0.00
Search more companies

Eumark Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Eumark Pharmaceuticals Pvt Ltd Profile Updated: January 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Eumark Pharmaceuticals Pvt Ltd is an unlisted company, incorporated on 30/03/1984. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U24230MH1984PTC032534 and registration number is 032534. The company is a manufacturing, support service to organizations company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, other support services to organizations.

Legal Address
A-22, Midc, Additional Ambernath, Ambernath East
Thane; Maharashtra; Postal Code: 421506

Contact Details: Purchase the Eumark Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Eumark Pharmaceuticals Pvt Ltd report to view the information.
Outstanding Shares:
Purchase the Eumark Pharmaceuticals Pvt Ltd report to view the information.
Registered Capital:
Purchase the Eumark Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
March 30, 1984
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Eumark Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-11.64%
Total operating revenue
-10.02%
Operating profit (EBIT)
12.36%
EBITDA
12.94%
Net Profit (Loss) for the Period
12.06%
Total assets
18.99%
Total equity
15.34%
Operating Profit Margin (ROS)
1.35%
Net Profit Margin
1%
Return on Equity (ROE)
-0.39%
Debt to Equity Ratio
99.86%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?